Acadian Asset Management
SBBP

Acadian Asset Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Acadian Asset Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-64,053
Closed -$177K – 2309
2021
Q1 		$177K Buy
+64,053
New +$193K ﹤0.01% 1535
2020
Q4 		– Sell
-14,401
Closed -$30K – 2410
2020
Q3 		$30K Sell
14,401
-42,834
-75% -$144K ﹤0.01% 1989
2020
Q2 		$216K Sell
57,235
-48,484
-46% -$145K ﹤0.01% 1461
2020
Q1 		$199K Buy
105,719
+56,870
+116% +$148K ﹤0.01% 1198
2019
Q4 		$101K Buy
48,849
+37,669
+337% +$72.2K ﹤0.01% 1458
2019
Q3 		$27K Buy
11,180
+9,016
+417% +$24.2K ﹤0.01% 1690
2019
Q2 		$7K Sell
2,164
-6,612
-75% -$24.3K ﹤0.01% 1681
2019
Q1 		$44K Buy
+8,776
New +$43.2K ﹤0.01% 1703
2017
Q4 		– Sell
-16,955
Closed -$117K – 1720
2017
Q3 		$117K Buy
+16,955
New +$117K ﹤0.01% 986
2017
Q1 		– Sell
-360
Closed -$1K – 1844
2016
Q4 		$1K Hold
360
– – ﹤0.01% 1609
2016
Q3 		$2K Sell
360
-204
-36% -$920 ﹤0.01% 1367
2016
Q2 		$2K Sell
564
-809
-59% -$3.82K ﹤0.01% 1355
2016
Q1 		$6K Hold
1,373
– – ﹤0.01% 1249
2015
Q4 		$10K Buy
+1,373
New +$9.87K ﹤0.01% 1241

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Acadian Asset Management's SBBP Position: Q2 2021 in Review

Acadian Asset Management sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 64,053 shares — an estimated $177K sold.

Acadian Asset Management first reported a position in SBBP in Q4 2015 and held it in 14 quarters. The position peaked at $216K in Q2 2020. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

  • Acadian Asset Management reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
  • Acadian Asset Management sold 64,053 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $177K.
  • Acadian Asset Management first reported a position in Strongbridge Biopharma plc. in Q4 2015 and held it in 14 quarters.
  • Acadian Asset Management's Strongbridge Biopharma plc. position peaked at $216K in Q2 2020.
  • 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on Acadian Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.